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levels, with the majority of them (145 genes) downregulated in patients. Importantly, gene expression
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model and human infection, while the in vitro conditions displayed more substantial differences. Interest-
ingly, comparison of gene expression between the mouse model and human infection hinted at differences
in bladder oxygenation as well as nutrient composition. In summary, our work strongly validates the
continued use of this mouse model for the study of the pathogenesis of human UTI.
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ABSTRACT Uropathogenic Escherichia coli (UPEC) is the primary causative agent of
uncomplicated urinary tract infections (UTIs). UPEC fitness and virulence determi-
nants have been evaluated in a variety of laboratory settings, including a well-
established mouse model of UTI. However, the extent to which bacterial physiolo-
gies differ between experimental models and human infections remains largely
understudied. To address this important issue, we compared the transcriptomes of
three different UPEC isolates in human infection and under a variety of laboratory
conditions, including LB culture, filter-sterilized urine culture, and the UTI mouse
model. We observed high correlation in gene expression between the mouse model
and human infection in all three strains examined (Pearson correlation coefficients of
0.86 to 0.87). Only 175 of 3,266 (5.4%) genes shared by all three strains had signifi-
cantly different expression levels, with the majority of them (145 genes) downregu-
lated in patients. Importantly, gene expression levels of both canonical virulence fac-
tors and metabolic machinery were highly similar between the mouse model and
human infection, while the in vitro conditions displayed more substantial differences.
Interestingly, comparison of gene expression between the mouse model and human
infection hinted at differences in bladder oxygenation as well as nutrient composi-
tion. In summary, our work strongly validates the continued use of this mouse
model for the study of the pathogenesis of human UTI.
IMPORTANCE Different experimental models have been used to study UPEC patho-
genesis, including in vitro cultures in different media, tissue culture, and mouse
models of infection. The last is especially important since it allows evaluation of
mechanisms of pathogenesis and potential therapeutic strategies against UPEC.
Bacterial physiology is greatly shaped by environment, and it is therefore critical
to understand how closely bacterial physiology in any experimental model re-
lates to human infection. In this study, we found strong correlation in bacterial gene
expression between the mouse model and human UTI using identical strains, sug-
gesting that the mouse model accurately mimics human infection, definitively sup-
porting its continued use in UTI research.
KEYWORDS UPEC, transcriptome, human infection, mouse model of UTIs, UPEC
Urinary tract infections (UTIs) are among the most common bacterial infections inotherwise healthy individuals. Over 50% of women experience at least one UTI in
their lifetime, and half of these women experience a recurrent infection within a year
(1, 2). These infections affect 150 million people per year and result in annual medical
costs of $3.5 billion in the United States alone (3). Uropathogenic Escherichia coli (UPEC)
is responsible for 80% of uncomplicated UTIs (1) and deploys diverse strategies to
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survive and replicate in the human host. These comprise an array of virulence factors,
including, but not limited to, iron acquisition systems (siderophores and heme recep-
tors), fimbriae and other adhesins, flagella, and toxins (4–7). The importance of these
systems to bacterial fitness has been studied in detail using multiple models, including
cultures in laboratory media, human urine cultures, tissue culture, and a mouse model
first established over 30 years ago (8). However, animal models can fail to recapitulate
important aspects of the human response to disease (9). Whether the mouse model
accurately reflects the native environment found during human infection has not been
adequately addressed. Therefore, it is vitally important to determine if the mouse
model of ascending UTI recapitulates human UTI since defining mechanisms of patho-
genesis and the development of UTI therapies rely on this assumption (10).
Previous studies compared the mouse model to human UTIs using microarrays to
assess differences in bacterial gene expression (11, 12). Initially, urine from mice
infected with UPEC type strain CFT073 was collected over a period of 10 days, pooled,
and analyzed using a microarray based on the CFT073 genome (11). In a follow-up
study, urine was collected from eight women with complicated UTIs and bacterial gene
expression in the human host was analyzed, again using microarrays based on the
CFT073 genome (12). Relative expression levels of 46 fitness genes were compared
between the mouse model and human UTI. This comparison demonstrated a Pearson’s
correlation coefficient of 0.59 and was strongest for iron acquisition systems and
weakest for adhesin and motility systems (12). While encouraging, this study did not
provide conclusive evidence that the mouse model closely replicated human UTI. A key
weakness of the previous comparison was that genetic differences between currently
circulating isolates and strain CFT073 used for the mouse infections would obscure
strain-specific responses, either due to differences in mouse versus human UTI or
because the CFT073-specific microarrays would not detect expression of genes that are
not encoded by that strain.
We have recently used RNA sequencing (RNA-seq) to quantify the UPEC transcrip-
tome during acute infection in 14 female patients (13). Importantly, RNA-seq is a more
comprehensive platform to analyze the transcriptome of clinical UPEC strains since,
unlike microarrays, it is not limited by strain-specific probes. Here, we report the
transcriptome during murine UTI for 3 of the 14 clinical strains using RNA-seq and direct
comparison of the gene expression patterns for these identical strains between human
UTI and the mouse model. We observed a high correlation between human infection
and mouse infection (Pearson correlation coefficient ranging from 0.86 to 0.87), with
only 175 of 3,266 shared genes being differentially expressed. Gene expression of
classical virulence factors as well as metabolic genes in the mouse model closely
resembled those observed during human UTI. Our study is the first of its kind to directly
compare the bacterial transcriptomes between human and mouse UTIs using identical
strains. We conclude that the mouse model accurately reflects bacterial gene expres-
sion observed during human infection.
RESULTS
Study design. We previously sequenced the transcriptomes of 14 UPEC strains
isolated directly from the urine of patients with uncomplicated UTIs (hUTIs) and
immediately stabilized with RNAprotect (13). Three out of 14 strains (HM43, HM56, and
HM86) were chosen to conduct transcriptomic studies in the prevailing mouse model
of UTI (mUTI) (8). We selected strains whose hUTI transcriptomes had the highest
proportion of bacterial reads to eukaryotic reads (see Table S1 in the supplemental
material) and that possessed a prototypical UPEC virulence factor profile. All three
strains belong to the B2 phylogroup (13), which includes the majority of UPEC strains
and encode a range of siderophores, heme receptors, and multiple fimbrial types
(Fig. 1).
To compare UPEC gene expression levels during mUTI and hUTI, 40 mice were
transurethrally inoculated with each UPEC strain and mouse urine was collected directly
into RNAprotect, 48 h postinoculation (hpi), for RNA isolation and sequencing. Animals
Frick-Cheng et al. ®





















































FIG 1 Virulence factors present in selected clinical UPEC strains. Presence or absence of these 42 genes
was determined via BLAST (80% coverage and 90% identity). White indicates absence of the gene,
while black indicates presence. Color coding on gene names identifies the function of each virulence
factor. Goldenrod is iron acquisition, green is motility, blue is adhesins, and red is toxins. Sequence types
were determined computationally and reported by Sintsova et al. (13).
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were then sacrificed and the bacterial burdens of their urine, bladders, and kidneys
were quantified. All three strains successfully colonized the animals, with bacterial
burdens ranging between 5.0  103 and 4.4  104 CFU/g in the bladder and 1  104
and 1.2  106 CFU/g in the kidneys (Fig. 2A), levels of colonization that are consistent
with an active UTI. We also assessed levels of inflammation (on a scale from 0 to 3) in
the bladders and kidneys of these infected mice, comparing them to those of mice that
were mock infected with phosphate-buffered saline (PBS) (Fig. 2B and Fig. S1). After
48 h, infection with all of the three UPEC strains resulted in mild levels of inflammation
in the bladder (median inflammation scores of 1.0, 0.25, and 0.5 for HM43, HM56, and
HM86, respectively) and slightly higher levels in the kidneys (median inflammation
scores of 1.25, 1.5, and 1.0 for HM43, HM56, and HM86, respectively). These similar
scores indicated that the general host responses were comparable across these three
different strains.
In addition to isolating RNA from mouse urine during mUTI, we also isolated and
sequenced RNA from HM43, HM56, and HM86 cultured to mid-logarithmic phase in
both filter-sterilized human urine and lysogeny broth (LB). All samples processed in this
study underwent identical treatments to deplete eukaryotic mRNA, prepare libraries,
and conduct sequencing (see Materials and Methods).
The bacterial transcriptome is highly correlated between human and mouse
infections. First, we assessed how UPEC gene expression during hUTI compared to that
under in vitro conditions and during mUTI. For each strain, we compared log2 tran-
scripts per million (TPMs) of every gene between LB and hUTI, human urine culture and
hUTI, and, finally, mUTI and hUTI. Gene expression during hUTI and mUTI was most
highly correlated with the Pearson correlation coefficient (r), ranging from 0.86 to 0.87
(Fig. 3). In contrast, the in vitro human urine culture compared to hUTI exhibited lower
correlation values, 0.73 to 0.80 (Fig. 3), consistent with our previous report (13).
Interestingly, gene expression correlation between LB and hUTI was higher than the
FIG 2 Murine colonization and inflammatory response of selected clinical UPEC strains. CBA/J mice were
transurethrally inoculated with 108 CFU of the indicated strain (HM43, HM56, or HM86). (A) Bacterial
burden was enumerated from urine, bladder, and kidneys 48 h postinfection. Symbols represent indi-
vidual animals, and bars represent the medians. The dotted line indicates limit of detection. A two-tailed
Mann-Whitney test was performed to test significance. **, P  0.01; ***, P  0.005; ****, P  0.0001. (B)
Inflammation was assessed using histopathological analysis of stained thin sections of each specified
organ. Inflammation was scored on a scale of 0 to 3, with 0 being no inflammation and 3 being severe
inflammation. Mice were mock infected with PBS to serve as a negative control. Symbols represent
individual animals, and bars represent the medians.
Frick-Cheng et al. ®





















































correlation between urine and hUTI (r between 0.80 and 0.88) (Fig. 3). Our data
demonstrate that murine infection is the most reliable and consistent model to
recapitulate the conditions that are observed during human infection.
Contribution of growth rate to gene expression patterns. We have recently
shown that diverse UPEC strains show a conserved gene expression pattern in human
FIG 3 UPEC gene expression during mouse and human infections is highly correlated. Normalized levels of gene expression (log2 TPM) for three UPEC
strains—HM43 (A), HM56 (B), and HM86 (C)—were compared between LB culture and human infection (hUTI | LB), urine culture and human infection (hUTI |
urine), and mouse infection and human infection (hUTI | mUTI). Pearson correlation coefficient (r) is shown in the top left corner of each plot.
UPEC Transcriptome in Mice Correlates with Patient UTI ®





















































patients with uncomplicated UTIs (13). Since we saw such strong correlation between
gene expression in patients and in mice for each of the UPEC strains (Fig. 3), we
hypothesized that we would also observe a conserved pattern of gene expression
between different UPEC strains during mUTI. To address this hypothesis, we performed
principal-component analysis (PCA) on gene expression of the 3,266 genes present in
all three UPEC strains (Fig. 4A). We observed four distinct clusters that corresponded to
the two in vitro growth conditions (LB and filter-sterilized human urine cultures) and the
two infection hosts (human patients and mice) all displaying condition-specific gene
expression programs. Samples from patients and mice clustered closer to each other
than to in vitro samples, suggesting that there is an infection-specific gene expression
pattern conserved between the two hosts.
We further wanted to estimate the contribution of growth rate to similarity of gene
expression profiles between mUTI and hUTI since a major hallmark of the conserved
transcriptional program of UPEC in humans is rapid growth (13–15). When cultured in
FIG 4 Host-associated gene expression is distinct from that of in vitro culture. (A) Principal-component analysis of normalized gene
expression of 3 clinical UPEC strains during human infection (hUTI), during mouse infection (mUTI), during in vitro LB culture (LB), and in
in vitro urine cultures (urine). (B) Principal-component analysis of normalized r-protein expression of 3 clinical UPEC strains during human
infection (hUTI), during mouse infection (mUTI), during in vitro LB culture (LB), and in in vitro urine cultures. (C) Percent contribution from
r-proteins to PC1 and PC2 from the PCA shown in panel A. (D) Hierarchical clustering of in vitro, murine, and patient samples based on
normalized gene expression of genes present in all 3 strains (n  3,266).
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vitro, there was no appreciable difference in the growth rates of the UPEC strains
cultured in human urine (Fig. S2A and B). There appeared to be an extremely subtle
difference in growth rate in LB between HM43 and HM86 (Fig. S2C and D), which is
interesting given that these two strains had the largest difference in correlation
between hUTI and LB (r values of 0.81 and 0.88, respectively). However, while HM86 had
the highest correlation, it grew more slowly than HM43, indicating that it is potentially
more than just growth rate that drives this similarity.
We also performed PCA using only ribosomal protein expression data (Fig. 4B), since
expression of ribosomal proteins is directly correlated with bacterial growth rate (16,
17), as another method to dissect the contribution of growth rate. While this analysis
showed a clear difference between urine samples and other conditions, it failed to
clearly separate LB, mUTI, and hUTI samples (Fig. 4B). This suggests that while growth
rate undoubtedly shapes the gene expression pattern in mUTI and hUTI, growth rate
alone is insufficient to explain gene expression patterns observed in Fig. 3 and 4A.
Additionally, we looked at how much each of the ribosomal genes contributed to the
either principal component 1 (PC1) or principal component 1 (PC2) (Fig. 4C). We found
that all of the ribosomal genes contributed more to PC1 than to PC2 values. Thus, we
hypothesize that PC1 might in fact separate samples based on growth rate, while other
unknown factors account for sample separation along PC2.
The conclusions of PCA (clear separation of samples based on condition rather than
on strain) were independently confirmed using Ward’s hierarchical clustering of log2
TPM values (Fig. 4D). We also demonstrate that growth in rich medium (LB) more
closely mimics hUTI than growth in nutrient-poor human urine, in agreement with the
previously demonstrated rapid growth of UPEC in the host (both mouse and human)
compared to that in human urine (13–15, 18).
Differentially regulated genes between human and mouse infection suggest
nutritional disparities. Despite the high concordance of hUTI and mUTI gene expres-
sion data, we wanted to determine whether any genes are differentially regulated
between human and mouse infections. To answer this question, we used the R package
DEseq2 (19) to find significant differences in gene expression between the two different
infections. Strikingly, only 175 genes, representing 5.4% of the 3,266 genes analyzed,
were differentially regulated (30 upregulated and 145 downregulated) in human
infection compared to the mouse model (Fig. 5A, Tables 1 and 2, and Table S2).
The upregulated gene with the highest log2 fold change difference (4.3) between
humans and mice was cspA, which encodes an RNA chaperone initially identified as a
cold shock protein (20, 21). However, this protein may have other functions, as it is
highly expressed during early exponential phase (22) and during the introduction of
fresh nutrient sources (23). In addition, one of the genes responsible for cell division,
ftsB, and a major regulator of rRNA transcription, fis, were upregulated in hUTI com-
pared to mUTI.
The majority of differentially regulated genes were downregulated in patients
compared to mice, and several of these genes span operons encompassing specific
systems (Table 2 and Table S2). For example, during mUTI, we observed increased
expression of the citrate lyase operon citCDEFGTX, which is responsible for the conver-
sion of citrate oxaloacetate and acetate and feeds into the production of acetyl
coenzyme A (acetyl-CoA) under anaerobic conditions (24), the pathway for allantoin
breakdown (allABDC), and ethanolamine utilization (eutABCDEGHJLMNPQST) (Table 2
and Table S2). In addition, genes encoding transporters for the uptake of L-arabinose
(araADFGH), L-ascorbate (ulaABCDEDF), and allantoin (ybbW) were transcribed at higher
levels during mUTI (Table 2 and Table S2). Furthermore, several genes related to
anaerobic metabolism or fermentation (hycBDF and frdAB) were more highly expressed
in mice (Table 2 and Table S2). All of these results indicate subtle nutrient differences
between the mouse and human urinary tracts.
Infection-specific gene expression. Additionally, we were interested in identifying
genes that behaved similarly during both human and mouse infections, i.e., genes that
UPEC Transcriptome in Mice Correlates with Patient UTI ®





















































were up- or downregulated in both mouse and human UTIs compared to either of the
in vitro conditions (LB or filter-sterilized human urine). There were 54 downregulated
genes in both mouse and human UTIs compared to LB (Fig. 5B and Table S3), and there
were 67 upregulated genes during both mUTI and hUTI compared to LB (Fig. 5B and
FIG 5 Differential expression analysis reveals infection-specific gene expression responses. (A) The
DESeq2 R package was used to compare UPEC gene expression during mUTI to that in patients. Each
UPEC strain was considered an independent replicate (n  3). Genes were considered upregulated
(downregulated) if the log2 fold change in expression was higher (lower) than 1 (vertical lines) and the
P value was 0.05 (horizontal line). Using these cutoffs, we identified 30 upregulated genes and 145
downregulated genes in patients. GO/pathway analysis showed a number of transporters and catabolic
enzymes among differentially expressed genes. (B and C) Identification of genes differentially expressed
during infection (hUTI or mUTI) compared to LB (B) or urine (C). Genes were considered to be up- or
downregulated in both mice and humans if the log2 fold change was higher or lower than 1 and the P
value was 0.05 in both cases. Genes that were upregulated during infection compared to LB (B) or urine
(C) are shown in red, and genes that were downregulated during infection compared to LB are shown
in blue.
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Table S3). Interestingly, both chemotaxis (cheABWYZ) and flagellar machinery (flgCFGLM
and fliS) were downregulated during infection, which may be attributed to the fact that
the UPEC strains we analyzed were isolated from the urine of infected individuals;
motility genes tend to be upregulated when UPEC enters the ureters to ascend to the
kidneys (25). In contrast, nrdEFHI genes are upregulated in both mice and humans
compared to LB. These genes encode ribonucleotide reductases required for DNA
synthesis, and therefore often associated with fast growth, fitting the previously
established paradigm of UPEC’s high in vivo growth rate during human and murine
infections (13–15, 18).
There were 82 genes that were downregulated during either mUTI or hUTI com-
pared to urine (Fig. 5C and Table S4). These included branched-chain amino acid
biosynthesis (ilvCDEMN) and leucine biosynthesis (leuABCD) operons, consistent with
previous literature indicating that UPEC scavenges amino acids and peptides during
infection (13, 26). In contrast, there were 72 genes that were upregulated in humans
and mice compared to urine (Fig. 5C and Table S4). As previously reported (13), we
observed 16 genes associated with ribosomal subunit production as well as the master
regulator fis, which activates rRNA transcription, together reinforcing our observation
that bacteria grow rapidly in the host (13, 14).
Expression of fitness factors during murine infection is predictive of gene
expression during human infection. Finally, we wanted to determine whether pre-
viously identified UPEC virulence factors that have been studied using in vivo mouse
models would show comparable levels of expression during both mouse and human
infections. We focused on three major functional groups of fitness factors: iron acqui-
sition systems, adhesins, and metabolism (Table S5). We plotted log2 TPMs of the genes
in each functional group, comparing expression between hUTI and LB, hUTI and urine,
and hUTI and mUTI for each of the UPEC strains (Fig. 6 and Fig. S3).
TABLE 1 Genes differentially upregulated in human patients and mice
Gene Annotation Log2 FC
a Locus tag
ahpC Alkyl hydroperoxide reductase, AhpC component 2.6 b0605
cspA Cold shock protein CspA 4.3 b3556
dsdX D-Serine transporter 2.7 b2365
fis DNA-binding transcriptional dual regulator Fis 2.4 b3261
ftsB Cell division protein FtsB 2.3 b2748
gntK D-Gluconate kinase, thermostable 2.7 b3437
gpt Xanthine-guanine phsophoribosyltransferase 2.4 b0238
gspH Hypothetical type II secretion protein GspH 3.0 UTI89_C3381
gspL Hypothetical type II secretion protein GspL 3.3 UTI89_C3377
hpt Hypoxanthine phosphoribosyltransferase 2.1 b0125
ibaG Acid stress protein IbaG 2.2 b3190
lysP Lysine:H() symporter 2.1 b2156
opgC Protein required for succinyl modification of osmoregulated periplasmic glucans 2.6 b1047
ribE 6,7-Dimethyl-8-ribityllumazine synthase 2.1 b0415
rpmE 50S ribosomal subunit protein L31 2.7 b3936
suhB Inositol phosphate phosphatase 2.6 b2533
yajG Putative lipoprotein YajG 2.6 b0434
yceA UPF0176 protein YceA 3.5 b1055
yciB Inner membrane protein 2.3 b1254
ydiE PF10636 family protein YdiE 2.1 b1705
yecJ DUF2766 domain-containing protein YecJ 2.5 b4537
yejL DUF1414 domain-containing protein YejL 2.2 b2187
yfaZ Putative porin YfaZ 2.9 b2250
yfhL Putative 4Fe-4S cluster-containing protein YfhL 2.6 b2562
yghD Putative type II secretion system M-type protein 3.6 b2968
yghG Lipoprotein YghG 3.3 b2971
yifK Putative transporter YifK 3.6 b3795
yqcC DUF446 domain-containing protein YqcC 2.5 b2792
yqgF Ribonuclease H-like domain-containing nuclease 2.3 b2949
yqiA Esterase YqiA 2.3 b3031
aFC, fold change.
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As expected, iron acquisition gene expression was much higher during human
infection than during growth in rich LB medium (Fig. 6A). The expression levels were
more similar between urine culture (an iron-poor medium) and human infection, but
murine infection provided the most analogous profile (Fig. 6A). The only adherence
gene cluster that was highly expressed under any of the assayed conditions was the fim
operon, which encodes type 1 fimbriae. Expression of fim genes was higher in patients
than under either of the in vitro conditions but almost perfectly matched the expression
levels observed during mouse infection (Fig. 6B).
Anaerobic metabolic genes showed a major difference between human infection
and in vitro growth. The converse is also true; aerobic respiration genes, in particular,
were expressed at lower levels in humans than under either in vitro condition. Impor-
tantly, we also observed that the expression levels of aerobic respiration genes aligned
concordantly between humans and mice (Fig. 6C), while anaerobic respiration gene
expression was elevated in mice compared to that in humans. This observation
corroborates results in Fig. 5A, Table 2, and Table S2, where several genes involved in
anaerobic metabolism were expressed at higher levels in mice than in hUTI. Overall, we
conclude, with only limited exceptions, that the mouse model of UTI not only shows a
strong global correlation of gene expression with hUTI but also closely reflects the
expression of virulence and fitness genes that are known to contribute to UPEC fitness
during human infection.
DISCUSSION
UPEC virulence factors as well as potential therapeutic strategies have been studied
in detail using a well-established mouse model of ascending UTI that involves trans-
urethral inoculation of UPEC into the bladder. This mouse model has been extensively
used in the field, and the original papers defining this model (8, 27) have been cited
nearly 500 times. While this model has been the gold standard in the field to relate
scientific discovery to human health, there are some differences between the experi-
TABLE 2 Top 30 genes differentially downregulated in human patients and mice
Gene Annotation Log2 FC Locus tag
allB Allantoinase 7.0 b0512
allD Ureidoglycolate dehydrogenase 6.0 b0517
araA L-Arabinose isomerase 5.6 b0062
citC Citrate lyase synthetase 6.2 b0618
citD Citrate lyase acyl carrier protein 5.6 b0617
citG Triphosphoribosyl-dephospho-CoA synthase 5.5 b0613
citX Apo-citrate lyase phosphoribosyl-dephospho-CoA transferase 5.9 b0614
eutG Putative alcohol dehydrogenase in ethanolamine utilization 5.7 b2453
eutM Putative structural protein, ethanolamine utilization microcompartment 6.1 b2457
eutN Putative carboxysome structural protein 6.6 b2456
fdrA Putative acyl-CoA synthetase FdrA 6.2 b0518
frdA Fumarate reductase flavoprotein subunit 5.6 b4154
frdB Fumarate reductase iron-sulfur protein 5.3 b4153
frdC Fumarate reductase membrane protein FrdC 6.1 b4152
glxR Tartronate semialdehyde reductase 2 7.7 b0509
hycA Regulator of the transcriptional regulator FhlA 5.3 b2725
hycB Formate hydrogenlyase subunit HycB 6.0 b2724
ompW Outer membrane protein W 6.4 b1256
ssnA Putative aminohydrolase 5.3 b2879
tdcA DNA-binding transcriptional activator TdcA 6.2 b3118
tdcB Catabolic threonine dehydratase 5.5 b3117
ulaA L-Ascorbate-specific PTS enzyme IIC component 6.1 b4193
ulaB L-Ascorbate-specific PTS enzyme IIB component 5.8 b4194
ulaC L-Ascorbate-specific PTS enzyme IIA component 5.4 b4195
ybbW Putative allantoin transporter 6.7 b0511
ygeW Putative carbamoyltransferase YgeW 6.9 b2870
ygeY Putative peptidase YgeY 6.1 b2872
ygfK Putative oxidoreductase, Fe-S subunit 5.8 b2878
yhjX Putative pyruvate transporter 5.4 b3547
ylbE DUF1116 domain-containing protein YlbE 5.6 b4572
Frick-Cheng et al. ®





















































mental model and what occurs in human infection. In the murine model, 107 CFU are
inoculated directly into the mouse bladder, while in human infection, the number of
infecting bacteria is likely to be far lower and bacteria are not directly introduced into
the bladder. Rather, it is thought that in humans, the periurethral region is transiently
colonized by UPEC and bacteria ascend to the bladder and, in some cases, to the
kidneys (28). Furthermore, there are some differences in the immune responses be-
tween mice and humans. For example, mice express Toll-like receptor 11 (TLR11), which
induces host inflammation in response to UPEC and provides the kidneys with a
modest level of protection from bacterial colonization (29). However, humans do not
express TLR11 (29), indicating that not all murine responses precisely mimic the human
response. Therefore, it is of the utmost importance to validate the murine model of UTI
and understand the extent to which it recapitulates human disease. Until now, there
has been no direct comparison of global bacterial gene expression between human
and mouse studies using the identical strain, and it is essential to understand how the
mouse model relates to human disease. This study is the first to define the bacterial
transcriptome from infected patients and infected mice using the same UPEC strain,
thus presenting a direct comparison between the murine model and human infection.
FIG 6 Gene expression of virulence factors as well as metabolic machinery is highly consistent between the mouse model of UTI and human UTI. Normalized
levels of gene expression of iron acquisition operons (A), adherence genes (B), and metabolic pathways (C) for HM43 were compared between LB and human
infection (LB | hUTI), urine and human infection (urine | hUTI), and mouse UTI and human UTI (mUTI | hUTI).
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Our study demonstrates that the UTI mouse model accurately recapitulates the human
disease with respect to the bacterial transcriptional response.
We compared three UPEC strains (HM43, HM56, and HM86) that were isolated in
2012 from women with symptoms of cystitis and documented significant bacteriuria
(30). We isolated bacterial RNA, stabilized immediately, from their urine to conduct
RNA-seq and define the core bacterial transcriptome during acute human infection (13).
The same strains were then used for mouse infection, followed by urine collection,
bacterial RNA isolation, and sequencing. We consistently observed a high correlation
between the bacterial transcriptome during mouse and human infections, with the
Pearson correlation coefficient ranging from 0.86 to 0.87. This correlation is not strain
specific, as infections with all three stains showed similar results. Levels of expression
of virulence and metabolic genes were also found to be very similar between human
and mouse infections. While all three strains belonged to the B2 phylogroup, we do not
believe this to be a phylogroup-specific effect, as we have previously shown few
differences in gene expression between different UPEC phylogroups (13). This provides
strong evidence that the mouse model is an accurate representation of the infection
that occurs in humans, and by understanding which genes do not correlate between
humans and mice, we can further understand the limitations of the mouse model.
Mounting evidence suggests that UPEC organisms in the human host rapidly divide
(13, 14), and we have recently shown that this high growth rate is recapitulated in the
mouse model, although to a lesser degree (13). This difference in growth rate between
human and mouse UTIs potentially can be understood by examining the genes that are
differentially expressed between human and mouse infections. Most of the differen-
tially expressed genes were expressed at a lower level during hUTI than during mUTI
(145 of 175 genes). Many of these 145 genes are involved in anaerobic metabolism.
Several of them were clustered in operons encoding oxidoreductases involved in
fumarate or nitrite reduction. Additionally, genes involved in nutrient usage under
anaerobic conditions were also expressed at a lower level during hUTI, such as the all
operon, which encodes the catabolic pathway for allantoin degradation (a step in
purine catabolism [31]), or the ula operon, which encodes both an L-ascorbate trans-
porter and the corresponding enzymes for utilization of L-ascorbate, a compound that
can be present in urine due to its water-soluble nature (32). Therefore, we hypothesize
that the human bladder is better oxygenated than the mouse bladder. Indeed, a higher
oxygen level in human bladders might also account for the higher levels of replication
observed in hUTI (13), since an aerobic lifestyle can support more rapid growth. There
were also differences in transport systems involved in nutrient acquisition between
hUTI and mUTI. Arabinose transport (araADFGH) was expressed at a lower level in
humans; arabinose has been shown to be present in human bladders in micromolar
amounts when normalized to creatine (32). It is also present in murine bladders (33) but
has never been precisely quantified. It would be interesting if arabinose is present in
smaller amounts in humans than in mice, accounting for this difference in regulation.
One of the few genes that was upregulated in humans compared to mice was dsdX,
which encodes a D-serine transporter. Interestingly, D-serine is present in micromolar
amounts in human urine (34), D-serine utilization is associated with uropathogenic
strains (35, 36), and accumulation of D-serine leads to a “hypervirulent” phenotype (36,
37) in the urinary tract. Since there was an upregulation in D-serine transport, and not
in the deaminase required for its breakdown (dsdA), perhaps this presents a mechanism
to increase the intracellular levels of D-serine specific to hUTI.
We also compared the gene expression profiles of UPEC during infection with the
two most common in vitro models, LB cultures and pooled filter-sterilized human urine
cultures. Surprisingly, even though urine might seem to be the more physiologically
relevant medium for in vitro experimentation, LB overall provided a better model for
infection than urine cultures. Indeed, the correlations of strains grown in LB approached
the correlations found when comparing human infection to the mouse model (Fig. 3).
However, there were more differentially regulated genes between hUTI and LB (286
[data not shown]) than between mUTI and hUTI (174 genes). Furthermore, pathway
Frick-Cheng et al. ®





















































analysis using the online tool DAVID (38) revealed several pathways that were found to
be statistically significantly enriched (enrichment score  1.5) when comparing LB with
hUTI (Table S6) or LB with mUTI (Table S6). Several pathways were found to be shared
in both comparisons, specifically, iron homeostasis or acquisition as well as motility, and
various metabolism pathways (tricarboxylic acid [TCA], arginine and proline, and sulfur)
were differentially regulated between the LB and in vivo conditions (Table S6). Not only
do these results corroborate the results from Fig. 6, but also they point to shared
differences between either infection model and the in vitromodel, further underscoring
the similarities between mUTI and hUTI.
A major difference between in vitro growth of UPEC in LB or urine is growth rate, and
one of the major hallmarks of the transcriptional program of UPEC during infection is
rapid growth. When comparing the pathways enriched in the differentially regulated
genes between hUTI or mUTI and urine, ribosomes are found to be enriched (Table S7).
However, that is just one of seven other statistically significantly pathways that are
enriched; there is a variety of factors influencing this outcome. Furthermore, several of
these pathways (biosynthesis of amino acids, flavin adenine dinucleotide binding, and
nitrogen metabolism/nitrogen utilization) are shared between mUTI versus urine and
hUTI versus urine, implying that there are similarities between the two infections that
are not observed in in vitro growth in urine (Table S7).
There are several factors that vary between infection conditions and in vitro growth
that could account for the lower correlation between hUTI and urine culture gene
expression, for example, a nutrient limitation specific to in vitro growth. The bladder is
akin to a chemostat, with fresh urine constantly being introduced into the organ, a
condition that is not recapitulated under the in vitro conditions. Furthermore, the
collected urine is typically filter sterilized, and this method excludes exfoliated bladder
epithelial cells, likely another major source of nutrients for the pathogen during human
infection. In future studies, we could add lysed bladder cells from cell culture to
supplement the filter-sterilized urine and determine if this represents a better model of
the nutrient milieu. However, when studying specific systems, such as iron acquisition,
urine is a better model than LB, since it more accurately recapitulates the iron-limited
environment of the host.
In summary, while both in vitro models have advantages and disadvantages, the
mouse model offers a holistic representation of infection and accurately models UPEC
pathway expression. Detailed examination of gene expression profiles between mice
and humans allows us to understand which parts of the model are not recapitulated in
patients, so we may tailor our studies accordingly. This way the mouse model can serve
as a platform to answer questions that are more difficult or impossible to assess when
working with human patients.
MATERIALS AND METHODS
Bacterial culture conditions. Clinical UPEC strains HM43, HM56, and HM86 (30) were cultured
overnight in LB medium at 37°C with aeration. The next morning, cultures were centrifuged and the
pellets washed twice with PBS and then diluted 1:100 into either fresh LB medium or human urine. The
human urine was collected and pooled from at least four healthy female volunteers and passed through
a 0.22-m filter for sterilization. Bacteria were cultured at 37°C with aeration to mid-exponential phase
(3 h) and then stabilized in RNAprotect (Qiagen). Bacterial pellets were stored at –80°C until RNA
isolation.
Mouse infection. Forty female CBA/J mice were transurethrally inoculated, using the previously
established ascending model of UTI (8), with 108 CFU of either HM43, HM56, or HM86 that had been
cultured in LB overnight with shaking. The infection was allowed to progress for 48 h. Urine from five
mice was collected to enumerate bacterial burden, while the rest was collected for RNA (see below for
method). Mice were sacrificed, and their bladders and kidneys were aseptically removed, homogenized,
and plated to determine bacterial burden. Mouse urine was collected as previously described (13). Briefly,
at 48 hpi, urine was directly collected into RNAprotect, pooled, and pelleted. This was repeated every 45
min five more times, resulting in a total of six pellets. These pellets were stored at –80°C until RNA
isolation.
RNA isolation and library preparation. RNA was isolated as previously described (13). Briefly, all
bacterial pellets were treated with both lysozyme and proteinase K, and then total RNA was extracted
using an RNeasy kit (Qiagen). Genomic DNA was removed using the Turbo DNA-free kit (Thermo Fisher).
Eukaryotic mRNA was depleted using Dynabeads covalently linked with oligo(dT) (Thermo Fisher). The
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in vitro samples underwent the same treatment with Dynabeads to reduce any potential biases this
procedure might have introduced to the downstream sequencing. The supernatant was collected from
this treatment, and RNA was concentrated and repurified using the RNA Clean and Concentrator kit
(Zymo).
To compare the results of the new RNA-sequencing experiment to the published expression data
obtained with the human samples (13), the library preparation method needs to be identical to avoid
batch effects. The original sequencing data (hUTI) were obtained using the ScriptSeq Complete kit
(bacteria) to prepare the cDNA library. However, at the time of this study, Illumina had discontinued this
kit. Therefore, we needed to use any leftover kits that had the same base preparation method (ScriptSeq).
To accomplish this, we used the ScriptSeq Complete Gold kit (epidemiology), which also contains rRNA
removal for bacteria and eukaryotes for the HM86 mouse sample and all three HM43 samples (mouse,
LB, and urine). ScriptSeq Complete (bacteria) was used on the HM56 mouse sample, where the kit
contained rRNA removal for bacteria; mammalian rRNA was removed with Thermo Fisher’s mammalian
rRNA removal kit (catalog number 457012). Then the in vitro samples from both HM56 and HM86 were
prepared using the ScriptSeq Complete (bacteria) kit, which removes bacterial rRNA.
RNA sequencing. E. coli HM43 was sequenced using Illumina HiSeq2500 (single end; 50-bp read
length), and E. coli HM56 and HM86 were sequenced using Nextseq-500 under identical conditions
(single end; 50-bp read length).
Histology and tissue processing. Bladders were removed and halved by cutting on the transverse
plane, while kidneys were cut on the sagittal plane. One half of each organ was used to enumerate CFU,
while the other half was placed into tissue cassettes and immersion fixed in 10% formalin for at least 24 h.
The halves were then embedded in paraffin, cut into thin sections, and stained with hematoxylin and
eosin (H&E) by the In Vivo Animal Core at the University of Michigan. Tissue sections were scored as
described in Table 3. Briefly, this is a scale of 0 to 3, where 0 is no inflammation and 3 is severe
inflammation. Each organ section was scored by two different people in a blinded manner, and the
scores were averaged.
RNA-seq data processing. A custom bioinformatics pipeline was used for the analysis (https://
github.com/ASintsova/rnaseq_analysis). Raw fastq files were processed with Trimmomatic (21) to remove
adapter sequences and analyzed with FastQC to assess sequencing quality. Mapping was done with
bowtie2 aligner (39) using default parameters. Alignment details can be found in Table S1. Read counts
were calculated using HTseq htseq-count (40).
Pearson correlation coefficient calculation, PCA, and hierarchical clustering analysis. For PCA
and correlation analysis, transcripts per million (TPMs) were calculated for each gene; TPM distribution
was then normalized using log2 transformation, and these normalized data were used for both PCA and
correlation and hierarchical clustering analysis. Pearson correlation and PCA were performed using the
Python sklearn library. Hierarchical clustering was performed using Ward’s method and Euclidean
distance. All of the analyses were also performed using centered log-ratio transformation (instead of log2
transformation), which has recently been proposed for compositional data, and yielded similar results
(these results can be found in Jupyter notebook associated with this article). Jupyter notebooks used to
generate the figures are available at https://github.com/ASintsova/upec_mouse_model.
Differential expression analysis. Differential expression analysis was performed using the DESeq2
R package (19). Genes with a log2 fold change of greater than 1 or less than 1 and adjusted P values
(Benjamini-Hochberg adjustment) of less than 0.05 were considered to be differentially expressed.
Pathway analysis was performed using R package topGO (41).
Data availability. Jupyter notebooks as well as all the data used to generate the figures in this paper
are available on github: https://github.com/ASintsova/upec_mouse_model.
SUPPLEMENTAL MATERIAL
Supplemental material is available online only.
FIG S1, TIF file, 2.5 MB.
FIG S2, TIF file, 0.5 MB.
FIG S3, TIF file, 1 MB.
TABLE S1, XLSX file, 0.01 MB.
TABLE S2, XLSX file, 0.02 MB.
TABLE 3 Scoring criteria for histopathological analysis
Lesion
Description for score
0 1 2 3
Cystitis No scorable lesions Very rare PMNsa in stroma or
lumen or occasional
perivascular lymphoid cuffs
Many PMNs and moderate edema Many PMNs; widespread,
marked edema,
transmural inflammation
Pyelonephritis No scorable lesions Very occasional PMNs in lumen
or peripelvic tissue
Rafts of PMNs in the pelvis and/or
scattered focal aggregates of
PMNs in peripelvic tissue
Many PMNs in all sections,
or a single large focus
of PMNs in one section
aPMNs, polymorphonuclear leukocytes.
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TABLE S3, XLSX file, 0.02 MB.
TABLE S4, XLSX file, 0.02 MB.
TABLE S5, XLSX file, 0.02 MB.
TABLE S6, XLSX file, 0.01 MB.
TABLE S7, XLSX file, 0.01 MB.
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